Effect of glucagon on glucose production during insulin deficiency in the dog.
Open Access
- 1 September 1978
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 62 (3), 664-677
- https://doi.org/10.1172/jci109174
Abstract
The aim of the present experiments was to determine the effects of basal glucagon on glucose production after induction of prolonged insulin lack in normal conscious dogs fasted overnight. A selective deficiency of insulin or a combined deficiency of both pancreatic hormones was created by infusing somatostatin alone or in combination with an intraportal replacement infusion of glucagon. Glucose production (GP) was measured by a primed constant infusion of [3H-3]glucose, and gluconeogenesis (GNG) was assessed by determining the conversion rate of circulating [14C]alanine and [14C]lactate into [14C]glucose. When insulin deficiency was induced in the presence of basal glucagon the latter hormone caused GP to double and then to decline so that after 4 h it had returned to the conrol rate. The conversion of alanine and lactate into glucose, on the other hand, increased throughout the period of insulin lack. Withdrawal of glucagon after GP had normalized resulted in a 40% fall in GP, a 37% decrease in GNG, and a marked decrease in the plasma glucose concentration. Induction of insulin deficiency in the absence of basal glucagon resulted in an initial (30%) drop in GP followed by a restoration of normal GP after 2--3 h and moderately enhanced glucose formation from alanine and lactate. It can be concluded that (a) the effect of relative hyperglucagonemia on GP is short-lived; (b) the waning of the effect of glucagon is attributable solely to a diminution of glycogenolysis because GNG remains stimulated; (c) basal glucagon markedly enhances the GNG stimulation apparent after induction of insulin deficiency; and (d) basal glucagon worsens the hyperglycemia pursuant on the induction of insulin deficiency both by triggering an initial overproduction of glucose and by maintaining the basal production rate thereafter.This publication has 56 references indexed in Scilit:
- Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.Journal of Clinical Investigation, 1977
- Plasma glucagon immunoreactivity in a totally pancreatectomized patientDiabetologia, 1976
- Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.Journal of Clinical Investigation, 1976
- Somatostatin: Physiological and Clinical SignificanceAnnual Review of Medicine, 1976
- Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.Journal of Clinical Investigation, 1975
- An effect of glucagon on 3′,5′-cyclic AMP phosphodiesterase activity in isolated rat hepatocytesBiochemical and Biophysical Research Communications, 1975
- Studies on the inhibition of insulin release, glycogenolysis and gluconeogenesis by somatostatin in the rat islets of Langerhans and isolated hepatocytesBiochemical and Biophysical Research Communications, 1975
- Effects of Glucagon on Lipolysis and Ketogenesis in Normal and Diabetic MenJournal of Clinical Investigation, 1974
- Effect of Glucagon on Glucose Turnover and Plasma Free Fatty Acids in Depancreatized Dogs Maintained on Matched Insulin InfusionsCanadian Journal of Physiology and Pharmacology, 1972
- Pancreatic Glucagon Secretion in Normal and Diabetic SubjectsThe American Journal of the Medical Sciences, 1969